Skip to main content
  • Saved

made a Post

Engineered safety switch curbs severe side effects of CAR-T immunotherapy

Engineered safety switch curbs severe side effects of CAR-T immunotherapy

Source :

https://www.eurekalert.org/pub_releases/2021-03/ulcc-ess030321.php

UNC Lineberger Comprehensive Cancer Center researchers have demonstrated that an experimental safety switch incorporated as part of a chimeric antigen receptor-modified T cell therapy (CAR-T) was effective in reducing the severity of a neurotoxic side effect that occurred in a patient treated with CAR-T therapy for an aggressive form of leukemia.